STAT News

STAT+: Roche gets a lung cancer win with its KRAS drug divarasib

One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.

By STAT News

1 min read
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights